[HTML][HTML] Long-Term Effects of Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis

J Spijkerman, SMPJ Prevaes, EJM van Gils… - PloS one, 2012 - journals.plos.org
Background Shifts in pneumococcal serotypes following introduction of 7-valent
pneumococcal conjugate vaccine (PCV-7) may alter the presence of other bacterial …

Persistence of antibodies to severe acute respiratory syndrome coronavirus 2 in relation to symptoms in a nationwide prospective study

G den Hartog, ERA Vos… - Clinical Infectious …, 2021 - academic.oup.com
Background Assessing the duration of immunity following infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a first priority to gauge the degree of …

Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave

ERA Vos, G den Hartog, RM Schepp… - J epidemiol community …, 2021 - jech.bmj.com
Background We aimed to detect SARS-CoV-2 serum antibodies in the general population of
the Netherlands and identify risk factors for seropositivity amidst the first COVID-19 epidemic …

[HTML][HTML] Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands

J Spijkerman, EJM van Gils… - Emerging infectious …, 2011 - ncbi.nlm.nih.gov
To evaluate the effectiveness of the 7-valent pneumococcal conjugate vaccine (PCV7)
program, we conducted a cross-sectional observational study on nasopharyngeal carriage …

[HTML][HTML] Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the …

AATM Bosch, MA van Houten, JP Bruin… - Vaccine, 2016 - Elsevier
After introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the infant
national immunization program (NIP) in the Netherlands in 2006, Streptococcus …

[HTML][HTML] Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID …

LL van den Hoogen, G Smits, CCE van Hagen… - Vaccine, 2022 - Elsevier
Background With COVID-19 vaccine roll-out ongoing in many countries globally, monitoring
of breakthrough infections is of great importance. Antibodies persist in the blood after a …

[HTML][HTML] Molecular surveillance on Streptococcus pneumoniae carriage in non-elderly adults; little evidence for pneumococcal circulation independent from the …

AL Wyllie, LW Rümke, K Arp, AATM Bosch, JP Bruin… - Scientific reports, 2016 - nature.com
Carriage of Streptococcus pneumoniae in adults is rarely detected by the gold standard
culture method. With molecular tests of high sensitivity now available, we analysed upper …

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical …

J Spijkerman, RH Veenhoven, AJ Wijmenga-Monsuur… - Jama, 2013 - jamanetwork.com
Importance Immunization schedules with pneumococcal conjugate vaccine (PCV) differ
among countries regarding the number of doses, age at vaccinations, and interval between …

[HTML][HTML] Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal …

AL Wyllie, AJ Wijmenga-Monsuur, MA van Houten… - Scientific reports, 2016 - nature.com
Following the introduction of pneumococcal conjugate vaccines (PCVs) for infants,
surveillance studies on Streptococcus pneumoniae carriage have proven valuable for …

[HTML][HTML] SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics

LL van den Hoogen, MK Verheul, ERA Vos… - Scientific Reports, 2022 - nature.com
Abstract mRNA-and vector-based vaccines are used at a large scale to prevent COVID-19.
We compared Spike S1-specific (S1) IgG antibodies after vaccination with mRNA-based …